DBV Technologies publishes its financial reports for 2025

DBV Technologies announced the filing of its Form 10-K with the SEC in the United States and its 2025 Universal Registration Document in France. These documents include the annual financial report, the corporate governance report in accordance with the French Commercial Code, a description of the share buyback program, as well as the auditors' reports and fees.

Available online, these documents can be consulted on the websites of DBV, the SEC, and the AMF. The company, listed on Euronext Paris and Nasdaq, is continuing its research on the use of the VIASKIN® patch to treat food allergies, with a focus on young children. Its headquarters are in Châtillon, France, with North American operations in New Jersey.